|
Invited Speakers:
|
|
Regulation and Legislation
John Powers, PhD, Lead Medical Officer, Antimicrobial Drug Development and Resistance Initiatives, FDA
Alfred DeMaria, Jr., MD, Assistant Commissioner, Bureau of Communicable Disease Control, Massachusetts Department of Public Health
J. Todd Weber, PhD, Director, Office of Antimicrobial Resistance, CDC,
Fred Marsik, PhD, Division of Antiinfective and Opthalmology Products, Clinical Microbiology Team Leader, USFDA —Drug Discovery and Development
Christopher Lipinski, PhD, Scientific Advisor, Melior Discovery
Trevor Trust,PhD, FRSC, Head, Anti-infectives AstraZeneca
David Payne, PhD,Head, Microbiology, GlaxoSmithKline
William Fenical, PhD, University of California
Charles Rock, PhD, Leader, Small-Molecule Therapeutics, CIDC St. Jude Hospital
Margaret Riley, PhD, Director, Massachusetts Natural History Collections, Department of Biology, University of Massachusetts Amherst Economic Burden
Dominique L. Monnet, Pharm D, PhD, National Center for Antimicrobials and Infection Control, Denmark
Anthony White, PhD, UK, independent consultant
Susan Foster, PhD, APUA
Christopher-Paul Milne, DVM, MPH, JD, Tufts Center for the Study of Drug Development Public/Private Partnerships
Mark Perkins, MD, Foundation for Innovative New Diagnostics, Chief Scientific Officer
Barry Bunin, PhD, President, Collaborative Drug Discovery, Inc.
Erik M. Halvorson, Director of Business, Development Office of Technology Development, Harvard University
Martina Casenghi, PhD, Biologist, Campaign for Access to Essential Medicines, Médecins Sans Frontiéres Enabling Technologies
Fred C. Tenover, PhD, Associate Director for Laboratory Science, Division of Healthcare Quality Promotion, CDC —
Betsy Foxman, PhD, Professor of Epidemiology and Director, Center for Molecular and Clinical Epidemiology of Infectious Diseases,University of Michigan
Ekaterina Dadachova, PhD, Albert Einstein Collage of Medicine
John Mohr, Pharm D, University of Texas Medical School —
Jonathan Frye, PhD, USDA-ARS Biosecurity Applications
Mike Kurilla, MD, PhD, Director, Office of Biodefense Research Affairs, Division of Microbiology and Infectious Diseases, NIAID
Ravi Kane, PhD, Merck Associate Professor, Isermann Department of Chemical and Biological Engineering, Rennselaer Polytechnic Institute
James Petro, PhD, Chief, Knowledge Integration Program, Office of Research and Development, Science and Technology Directorate,Department of Homeland Security Invited
David Karaolis, PhD, Director, Department of Microbiology , National Bioforensic Analysis Center (NBFAC), National Biodefense, Analysis and Countermeasures Center (NBACC), US Deparmtment of Homeland Security
Jennifer Brower, PhD, Prometheus Principal Scientist and Adjunct Science and Policy Analyst, Rand Corporation
|
|